Complement C1r Activity Assay

Creative Biolabs offers specialized complement C1r activity assay services designed to characterize the functional activity of C1r, evaluate pathway-specific regulation, support inhibitor screening, and provide mechanistic insights for complement-targeted therapeutic development.

Submit Your Request Now

Download our service brochure

Inquiry

Understanding Complement C1r Function in the Classical Pathway

Complement C1r is a highly specialized serine protease that forms part of the C1 complex together with C1q and C1s. In the resting state, C1 circulates as an inactive macromolecular complex. Upon recognition of immune complexes, pathogen-associated structures, or antibody-bound targets through C1q, conformational changes occur within the C1 complex, leading to sequential activation of C1r and C1s.

Activated C1r initiates a proteolytic cascade by cleaving and activating C1s, which subsequently processes downstream complement components including C4 and C2. This ultimately contributes to formation of the classical pathway C3 convertase and progression toward complement amplification and terminal pathway activation. Because C1r acts at an early checkpoint of classical pathway activation, changes in C1r activity can significantly influence the intensity and duration of complement responses. Therefore, accurate evaluation of C1r functional activity is essential for understanding complement biology and developing selective complement intervention strategies.

Functional evaluation provides additional information regarding:

Enzymatic activation capability
Substrate cleavage efficiency
Pathway initiation capacity
Response to inhibitors or regulators
Species-specific functional differences
Therapeutic modulation potential

A biologically inactive or partially impaired C1r protein may still be detectable using binding-based assays. Functional assays overcome this limitation by directly measuring enzymatic performance and biological consequences. Creative Biolabs' complement C1r activity assay platforms are designed to bridge this gap by providing quantitative measurements of C1r-mediated activity.

Great Minds Choose Creative Biolabs

Partner with Us

Our Complement C1r Activity Assay Platforms

Creative Biolabs provides flexible C1r functional testing approaches depending on research objectives, sample availability, and therapeutic development stage.

Direct C1r Protease Activity Assay

The direct protease activity assay is designed to measure the enzymatic function of activated or activatable C1r under controlled experimental conditions. This format is useful when the primary objective is to determine whether C1r is functionally active, compare enzyme preparations, or evaluate direct inhibition of C1r proteolytic activity.

C1r-Mediated C1s Activation Assay

One of the most biologically relevant functions of C1r is activation of C1s within the C1 complex. Therefore, Creative Biolabs can design assays that evaluate the ability of C1r to activate C1s in a controlled system. This assay format can be especially useful when researchers need to understand whether C1r activity is functionally translated into classical pathway initiation.

Classical Pathway Reconstitution Assay

For projects requiring greater biological context, Creative Biolabs can establish reconstituted classical pathway systems using selected purified complement components. This approach allows careful control over pathway composition while preserving relevant cascade relationships. A reconstitution assay may involve C1q, C1r, C1s, C4, C2, and other downstream components depending on the study goal.

Serum-Based Classical Pathway Activity Assay

Serum-based assays provide a more physiologically relevant system for evaluating C1r function within the broader complement network. In this format, human or animal serum is used as the complement source, and classical pathway activation is triggered using appropriate immune-complex-like or antibody-mediated stimuli.

C1r Inhibitor Screening Assay

C1r is an attractive target for selective regulation of the classical pathway. Creative Biolabs provides customized inhibitor screening assays for identifying and characterizing C1r-targeting molecules. The assay can be configured for primary screening, confirmation testing, dose-response analysis, or lead ranking.

C1r Variant and Mutation Functional Characterization

Creative Biolabs can support functional characterization of C1r variants using customized assay formats. Functional readouts can help determine whether a variant causes loss of function, gain of function, altered activation kinetics, reduced substrate processing, or impaired interaction with C1s.

Assay Workflow	Description
Sample Preparation	Samples may include: Recombinant C1r proteins Purified complement components Human serum samples Animal serum samples Complement-depleted serum Engineered biological molecules Candidate complement inhibitors Sample preparation strategies are customized according to assay requirements.
C1r Activation and Reaction Setup	The C1r protein is introduced into an optimized reaction environment that supports: Proper folding Enzymatic activation Interaction with relevant complement components Controlled substrate exposure
Functional Detection	Depending on project goals, C1r activity may be detected through: Protease substrate cleavage assays Complement component activation measurements Immunoassay-based detection Fluorescent activity readouts Luminescent detection systems Cell-associated complement response assays
Data Analysis	Generated data may include: Relative C1r activity Enzyme activity curves IC50 values for inhibitors Activation profiles Comparative functional analysis

Discuss Your Needs

Applications of Complement C1r Activity Assay

Complement Therapeutic Development

C1r activity assays can support development programs.

Screening and Characterization of C1r Inhibitors

Selective inhibition of C1r represents a potential strategy for controlling classical pathway activation.

Autoimmune Disease Research

Excessive classical pathway activation contributes to immune complex-driven inflammation.

Complement Biology Research

C1r assays provide valuable tools for basic research.

Workflow of Complement C1r Activity Assay

Creative Biolabs follows a structured workflow to ensure that each C1r assay is aligned with client goals and delivers interpretable results.

Complement C1r assay. (Creative Biolabs Original) Fig. 1 Complement C1r activity assay workflow.

Design Your Workflow

Assay Readout Options

To meet diverse research needs, Creative Biolabs can provide multiple detection strategies for complement C1r activity assays.

Fluorometric Readout

High sensitivity
Kinetic measurement capability
Suitability for inhibitor screening
Broad dynamic range
Compatibility with microplate formats

Colorimetric Readout

Simple detection workflow
Convenient endpoint measurement
Good compatibility with routine plate readers
Cost-effective assay setup

ELISA-Based Readout

Target-specific detection
Suitable for serum and biological matrices
Good quantitative capability
Compatibility with biomarker-style analysis

Western Blot or Immunoblot-Based Detection

Confirming substrate cleavage
Detecting activation fragments
Comparing variant activity
Investigating unusual cleavage profiles
Validating assay mechanisms

Cell-Associated Complement Readouts

Complement deposition on target surfaces
C3b or C4b deposition
Membrane attack complex formation
Cell viability or lysis
Complement-mediated inflammatory markers

Customized Assay Development Strategy

Because C1r functions as part of the C1 complex and classical pathway cascade, no single assay format is optimal for every project. Creative Biolabs emphasizes customized assay design based on the biological question being asked.

Consideration	Description
Defining the Main Research Question	Clarifying the primary question helps determine the most appropriate assay format and readout. Examples include: Does a recombinant C1r protein show expected enzymatic activity? Does a candidate inhibitor directly block C1r? Does a therapeutic molecule suppress classical pathway activation upstream of C4? Does a patient-derived sample show altered classical pathway initiation? Does a C1r variant retain the ability to activate C1s? Does an engineered molecule selectively inhibit C1r without broadly suppressing complement?
Selecting the Appropriate Biological System	Different systems provide different levels of mechanistic control and biological relevance. Creative Biolabs can help match the assay system to the project objective. For example: Purified enzyme assays offer direct measurement of protease function. Reconstitution assays provide controlled pathway context. Serum-based assays reflect matrix and regulatory effects. Cell-associated assays reveal biological consequences of complement activation.
Optimizing Reaction Conditions	Optimization is particularly important for enzyme assays because signal quality depends strongly on reaction linearity and substrate availability. Key parameters may include: Protein concentration Substrate concentration Incubation time Temperature Buffer composition Calcium dependency Ionic strength Serum dilution Pathway activator concentration Inhibitor pre-incubation time Detection window
Establishing Controls	Appropriate controls improve data reliability and interpretation. Controls can be customized to distinguish C1r-specific activity from background protease activity or downstream complement effects. Potential controls include: No-enzyme control Heat-inactivated sample control Positive C1r activity control Negative inhibitor control Known pathway inhibitor control No-substrate control C1r-deficient or depleted matrix Reconstitution control Vehicle control Isotype control for antibody candidates Non-specific protease control
Data Interpretation and Reporting	Creative Biolabs can provide quantitative and comparative data analysis depending on assay type. Reports may include: Assay principle and workflow summary Sample information Experimental conditions Raw and processed data Standard curve or calibration information Activity comparison Dose-response curves IC50 or EC50 estimation when applicable Statistical analysis Interpretation notes Recommended next-step assays

Design Your Customization

Case Studies

Case 1

Initial Library Screening of C1r-Binding by Surface Plasmon Resonance

To identify compounds with non-specific binding behavior in SPR screening platform and/or low solubility in aqueous SPR buffers, each compound was initially subjected to a ‘clean screen'. A total of 381 compounds failed the clean screen. The remaining 1619 compounds that passed the clean screen were carried forward to direct C1r-binding assays. Each compound was injected over immobilized full-length human C1r.

Identify and characterize novel C1r-binding small-molecule fragments. (OA Literature) Fig. 2 Direct binding of compounds to full-length C1r by SPR.^1,2

References

Rushing, Blake R., et al. "Targeting the initiator protease of the classical pathway of complement using fragment-based drug discovery." Molecules 25.17 (2020): 4016. https://doi.org/10.3390/molecules25174016
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"We needed more than a binding readout for our classical pathway inhibitor program. The C1r activity assay helped us understand whether our lead molecule truly blocked early pathway initiation rather than only binding the enzyme. The data gave our discovery team a clearer basis for lead ranking and follow-up mechanistic studies."

— Principal Scientist, Complement Therapeutics Company

"Our project involved a difficult biological matrix and multiple downstream complement markers. Creative Biolabs helped design a C1r-focused workflow that included direct enzymatic activity testing and downstream pathway analysis. The customized approach was very useful for separating direct C1r inhibition from broader serum matrix effects."

— Director of Translational Immunology, Biopharmaceutical R&D Group

"The assay team provided a practical strategy to evaluate C1r-mediated C1s activation and classical pathway progression. The results helped us refine our understanding of how our candidate affected the C1 complex. We appreciated the scientific communication and detailed data interpretation."

— Senior Research Manager, Antibody Discovery Program

"Species differences were a major concern for our preclinical program. Creative Biolabs helped us compare activity profiles in human and animal complement systems and identify which assay formats were most informative for our candidate. This was important for selecting appropriate follow-up models."

— Preclinical Development Lead, Immunology-Focused Biotech Company

Frequently Asked Questions

Can the assay distinguish direct C1r inhibition from downstream complement inhibition?

Yes. Assay design can help distinguish whether a test molecule directly inhibits C1r or suppresses complement activation at another step. For example, a direct C1r enzymatic activity assay can evaluate whether the molecule blocks C1r protease activity itself. A C1r-mediated C1s activation assay can determine whether C1r-dependent activation of C1s is affected. Downstream assays measuring C4, C3, or C5b-9 activation can show whether classical pathway propagation is suppressed. By combining upstream purified-protein assays with serum-based pathway assays and appropriate controls, Creative Biolabs can help clarify the likely mechanism of inhibition.

What types of samples can be tested?

Potential sample types include purified C1r, recombinant C1r, native C1r preparations, engineered C1r variants, C1 complex preparations, purified complement component mixtures, human serum, animal serum, complement-depleted serum, reconstituted complement matrices, plasma-derived samples, biological fluids, cell culture supernatants, and candidate inhibitors. Test articles may include antibodies, small molecules, peptides, engineered proteins, fusion proteins, nanobodies, aptamers, biomaterials, nanoparticles, or other customized materials. Sample suitability depends on assay format, available detection reagents, matrix interference, species, and the specific functional question being addressed.

Can the assay be customized for different species?

Yes. Complement proteins and therapeutic candidates can show important species-dependent differences. Creative Biolabs can customize C1r activity assay strategies for human, mouse, rat, rabbit, cynomolgus monkey, non-human primate, or other client-defined species, depending on reagent availability and assay feasibility. Species-specific assay development may involve optimization of complement protein sources, serum matrices, detection antibodies, substrates, pathway activators, and controls. Cross-species testing is especially useful for preclinical programs that need to compare candidate activity in human and animal systems.

Can C1r activity assays be combined with other complement tests?

Yes. C1r activity assays can be integrated with a wide range of complement testing services to build a comprehensive pathway profile. Common companion assays include C1q binding assays, C1s activity assays, C4 activation assays, C2 activity assays, C3 activity assays, C5 activity assays, CH50 assays, C3b deposition assays, C5b-9 deposition assays, complement inhibition functional assays, and cell-based complement activity assays. Combining multiple assays can help distinguish upstream pathway initiation effects from downstream amplification, terminal pathway activation, or cell-surface complement injury.

What is the difference between C1r activity assays and C1q binding assays?

C1q binding assays evaluate recognition events at the beginning of classical pathway activation, such as whether C1q binds immune complexes, antibodies, surfaces, or candidate molecules. C1r activity assays evaluate a later functional step within the C1 complex, specifically whether C1r becomes enzymatically active and contributes to activation of C1s. A molecule may affect C1q binding without directly affecting C1r activity, or it may inhibit C1r after C1q recognition has occurred. Combining C1q binding assays with C1r activity assays can provide a more complete understanding of early classical pathway regulation.